Danaher Corporation

DHR

Danaher Corporation (DHR) is a global science and technology innovator that designs, manufactures, and markets professional, medical, industrial, and consumer products and services. Founded in 1984, the company operates through various segments, including life sciences, diagnostics, and environmental & applied solutions, serving customers in health, environmental, and industrial markets worldwide. Danaher is known for its focus on continuous improvement and leveraging science and technology to solve complex problems.

$203.83 -1.18 (-0.58%)
Dividend Yield 0.71%
Payout Frequency Quarterly

Dividend History

🎉 Upcoming Dividend

Investors can expect a dividend payout of $0.40 per share, scheduled to be distributed in 13 days on July 31, 2026

Pay DateAmountEx-DateRecord Date
July 31, 2026$0.402026-06-262026-06-26
April 24, 2026$0.402026-03-272026-03-27
January 30, 2026$0.322025-12-262025-12-26
October 31, 2025$0.322025-09-262025-09-26
July 25, 2025$0.322025-06-272025-06-27

Dividends Summary

Company News

Global Biochemistry Analyzer Market to Reach $8.18 Billion by 2035 as Diagnostic Testing Demand Accelerates
GlobeNewswire Inc. • Researchandmarkets.Com • July 15, 2026

The global biochemistry analyzer market is projected to reach $8.18 billion by 2035, driven by increasing diagnostic testing demand, adoption of fully automated systems, artificial intelligence integration, and rising preventive screening programs. The market encompasses various product types, modalities, and applications across hospitals, diagno...

Molecular Biology Enzymes, Reagents and Kits Market Size Worth USD 70.85 Billion by 2035 | SNS Insider
GlobeNewswire Inc. • Sns Insider • July 3, 2026

The global molecular biology enzymes, reagents and kits market is projected to grow from USD 27.69 billion in 2025 to USD 70.85 billion by 2035, with a CAGR of 9.68%. Growth is driven by increasing adoption of precision medicine, molecular diagnostics, genomics research, and biotechnology R&D. The US market is expected to reach $23.54 billion and...

Spatial Genomics and Transcriptomics Market Size to Reach USD 1.90 Billion by 2035, Growing at a 12.23% CAGR | SNS Insider
GlobeNewswire Inc. • Sns Insider • June 30, 2026

The global spatial genomics and transcriptomics market is projected to grow from USD 0.60 billion in 2025 to USD 1.90 billion by 2035 at a 12.23% CAGR. Growth is driven by increased adoption of AI-powered spatial biology technologies, precision medicine initiatives, and high-resolution molecular profiling in oncology and translational research. N...

Oxidative Stress Assay Market Size to Reach USD 3.25 Billion by 2035 | SNS Insider
GlobeNewswire Inc. • Sns Insider • June 29, 2026

The global Oxidative Stress Assay Market is projected to grow at a CAGR of 9.53% from 2026 to 2035, driven by rising chronic disease prevalence, pharmaceutical R&D investments, and advancements in biomarker diagnostics. North America leads with 38.52% market share, while Asia-Pacific is expected to show the highest growth rate at 10.55%. ELISA te...

Stock Market Today, June 25: Bio-Techne Surges After Merck KGaA Announces $73-Per-Share Cash Acquisition Offer
The Motley Fool • Josh Kohn-Lindquist • June 25, 2026

Bio-Techne shares surged 20% after Merck KGaA announced a $73-per-share cash acquisition offer. The deal comes one week after activist investor Ananym Capital Management built a stake and pushed for a sale. Trading volume reached 51.3M shares, significantly above average. Merck KGaA expects to achieve over $150 million in annual cost synergies wi...

Related Companies